etacstil developmental code names orally active nonsteroidal combined selective estrogen receptor modulator serm selective estrogen receptor degrader serd developed treatment estrogen receptorpositive breast shown overcome antiestrogen tamoxifen aromatase inhibitor fulvestrant resistance breast cancer altering shape estrogen receptor thus exhibiting serd etacstil tamoxifen derivative one first drugs overcome tamoxifenresistance predecessor etacstil prodrug metabolite analogous case tamoxifen prodrug afimoxifene etacstil developed early duke university glaxo wellcome later bristol myerssquibb bms acquired dupont nonscientific corporate reasons closed trial abandoned release etacstil metabolite many dormant years recent resurgence interest serds led development brilanestrant structural analogue httpsenwikipediaorgwikietacstil